CSIMarket Company Name, Ticker, Industry, else..
 
Phenomex Inc   (NASDAQ: CELL)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 99
 Employees 114
 Revenues (TTM) (Millions $) 72
 Net Income (TTM) (Millions $) -125
 Cash Flow (TTM) (Millions $) -112
 Capital Exp. (TTM) (Millions $) 2

Phenomex Inc
Phenomex Inc. is a multinational company, specializing in the development and production of advanced scientific instruments and analytical solutions. The company is known for its innovative and cutting-edge technology that is used in various industries, including healthcare, pharmaceuticals, biotechnology, and environmental sciences. Phenomex Inc. offers a wide range of products, such as chromatography systems, mass spectrometry instruments, laboratory equipment, and consumables. The company aims to provide accurate, reliable, and efficient solutions to researchers and scientists in order to enhance their understanding and analysis of complex scientific phenomena. With a global presence, Phenomex Inc. is committed to supporting scientific advancements and helping its customers achieve their research objectives.


   Company Address: 5858 Horton Street, Suite 320 Emeryville 94608 CA
   Company Phone Number: 858-2855   Stock Exchange / Ticker: NASDAQ CELL


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BNGO        45.13% 
BEAM        5.56% 
DNA        21.68% 
EDIT        17.39% 
NTLA        3.95% 
REGN        3.95% 
• View Complete Report
   



Phenomex Inc

Phenomex Inc's Fiscal Downturn: Revenue Plunges by 26.668% in Latest Quarter, Raises Concerns for Future Prospects



Phenomex Inc, a company specializing in [insert industry/sector], recently released its financial results for the second quarter of 2023. The report showcases weak business performance, resulting in a rise in losses. This article aims to interpret the financial results, highlighting the implications they may have on Phenomex Inc's future prospects.
1. Substantial Losses:
The second quarter saw an increase in losses, with the shortfall per share rising from $-0.38 to $-0.51. This signals a concerning trend that the company needs to address promptly.
Phenomex Inc

Phenomex Inc Defies Financial Challenges, Decreases Losses and Sets Path to Recovery

Despite facing some challenging financial situations in the first quarter of 2023, Phenomex Inc continues to move forward with optimism and determination. The company's revenue may have decreased by 8.364%, but the good news is that Phenomex Inc was able to decrease its loss per share from $-0.40 to $-0.31 per share. This is a clear indication that the company is taking the necessary steps to turn things around and regain its footing.
It is important to note that Phenomex Inc is not alone in experiencing a decline in revenue and an increase in deficit. Many companies in the healthcare sector are facing similar challenges due to lower demand. However, what sets Phenomex Inc apart is their resilience and strategic approach to tackling these issues head-on.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com